More recently, clinical research focused on the relation between soft tissue quantity and quality and peri-implant tissue health. Based on systematic reviews and clinical studies, the soft tissue quality and quantity appear to play a crucial role in maintaining or improving periimplant health over time (Akcali et al., 2017; Gobbato, Avila-Ortiz, Sohrabi, Wang, & Karimbux, 2013) .
Various techniques and materials were described in the literature to augment soft tissue volume, with the autogenous subepithelial connective tissue graft (SCTG) being considered the gold standard (Bassetti, Stahli, Bassetti, & Sculean, 2016; Thoma, Buranawat, Hammerle, Held, & Jung, 2014) .
However, the use of autogenous soft tissue is associated with a number of disadvantages predominantly related to an increased patient morbidity and inter-individual variations in terms of tissue quality and quantity that can be harvested (Benninger, Andrews, & Carter, 2012; Burkhardt, Hammerle, Lang, Research Group on Oral Soft Tissue, & Wound, 2015) . To overcome such limitations, a threedimensionally stable collagen matrix (VCMX) was developed and subsequently evaluated in numerous preclinical and clinical studies, demonstrating favourable short-term results (Thoma et al., 2010 (Thoma et al., , 2016 Zeltner, Jung, Hammerle, Husler, & Thoma, 2017) .
While there is some evidence that pontic and implant sites, grafted with autogenous transplants, maintain augmented tissue volume up to 10 years, similar data for soft tissue substitutes are lacking (Bienz, Sailer, et al., 2017) .
The aim of this clinical study was therefore to assess peri-implant tissue health, stability and volume changes at implants sites, previously augmented with VCMX or SCTG, from the insertion of singletooth reconstructions to 1 year.
| MATERIALSANDMETHODS

| Studydesign
The present investigation was designed as a follow-up study of (Thoma et al., 2016) . The study and its procedures were approved by the local ethics committee (KEK-ZH-Nr 2012-0226). The time point, 2 weeks following the insertion of the final reconstruction, was considered as baseline (BL).
The following inclusion criteria were applied at BL for the present follow-up study:
2.1.1 | Inclusioncriteria 1. Patients previously enrolled into the previous RCT (Thoma et al., 2016) comparing augmented soft tissue volume by the use of an SCTG or VCMX (Geistlich Fibro-Gide ® Geistlich Pharma AG, Wolhusen, Switzerland),
2.
Final restoration inserted at implant site, and 3. Ability to fully understand the nature of the proposed non-interventional long-term follow-up study and the ability to sign the informed consent form.
| Exclusioncriteria
1. Newly developed disease interfering with soft tissue regeneration (e.g. diabetes),
2.
Peri-implant infection (not related to previously performed soft tissue regeneration) following the insertion of the final reconstruction,
3.
Second soft tissue augmentation since completion of study (Thoma et al., 2016) ,
4.
Severe trauma to implant site, and 5. Orthodontic treatment in the same quadrant.
| Clinicalprocedures
All participants were previously enrolled into a randomized controlled clinical trial (Thoma et al., 2016) . In brief, 20 patients with a soft tissue volume deficiency after the placement of a single-tooth implant were randomly allocated to receive a soft tissue augmentation using VCMX or SCTG. Three months after soft tissue grafting, abutment connection was performed and final reconstructions fabricated and inserted. This study was then designed as a noninterventional study following the insertion of final reconstructions (all screw-retained, single-tooth crowns). Two weeks after the insertion of final reconstructions, baseline measurements were performed (BL) and patients re-examined at 6 months and 1 year. 
Clinical Relevance
| Assessmentofthevolumetricchanges
At BL, 6 months (6M) and 1 year (FU-1), impressions of the implant sites were taken using an A-silicone impression material (President, Coltene/whaledent) including at least the two neighbouring teeth and the respective mucosa. Dental stone casts were fabricated (Fujirock, Picodent) and optically scanned with a desktop 3D scanner (Imetric 3D, Courgenay, Switzerland). Subsequently, the obtained STL files were imported into a digital imaging software program (SMOP; Swissmeda, Zurich, Switzerland). A region of interest (ROI) was defined with a trapezoid shape. The ROI encompassed the following borders: 1 mm apical of the margo mucosae (coronal), the mucogingival junction (apical) and 1 mm distance from the neighbouring tooth (mesial, distal). This ROI varied between patients, due to individual anatomical situations, but was kept constant in each patient and site over time. The images of the baseline and follow-up STLs were superimposed and matched using the best-fit algorithm at the adjacent tooth surfaces. The volumetric changes were calculated by the software measured in mm, which corresponded to the mean distance between the three surfaces representing the evaluated time points (BL, 6M and FU-1).
| Assessmentofperiodontalstatus
At BL, 6M and FU-1, standard clinical and periodontal measurements were performed at the implant sites and the two neighbouring teeth:
the plaque index (PlI), the width of keratinized tissue (KT) at the buccal aspect, bleeding on probing (BOP) and probing depth (PD).
| Assessmentofthesofttissuesituation
The pink aesthetic score (PES; Furhauser et al., 2005 ) was recorded at BL, 6M and FU-1, evaluating the soft tissues around the implants encompassing seven parameters and scores from 0 (poorest) to 2 (best).
The highest achievable score was 14.
| Patient-reportedoutcomemeasures
At BL, 6M and FU-1, an oral health impact profile questionnaire (OHIP-G14) was filled out by the patients.
| Statisticalanalysis
Mean, median, standard deviation and the quartiles Q1 and Q3 were used to describe the continuously scaled variables (expressed as median is not generally conservative in noninferiority trials).
As this was a follow-up investigation of a previously performed randomized controlled clinical trial, the sample size resulted out of the corresponding published study (Thoma et al., 2016) .
| RESULTS
All 20 patients originally included in the RCT entered the followup examination (baseline) between November 2012 and April 2015.
Ten patients (mean age 44.1 ± 12.8 years) had been treated with a VCMX (seven females, three males) and 10 patients (mean age 43.4 ± 18.8 years) with a SCTG (six females, four males). A detailed description of patient demographics and augmentation sites is displayed in Tables 1 and 2 . No relevant differences regarding baseline periodontal parameters were observed between the two groups.
One patient in group VCMX was lost to follow-up after the baseline examination due to emigration. The remaining 19 patients attended all follow-up appointments, and data were included in the analyses.
| Softtissuethickness
The median thickness of the mucosa at baseline was 3.0 mm Table 3 .
| Volumetricchanges
The descriptive data for the volume changes between BL, 6M and FU-1 are presented in Table 4 Mean ± SD 2.9 ± 0.9 3.0 ± 0.9 
| Assessmentofthesofttissuesituation
At BL, median PES scores were 9.0 (9.0;11.0) for VCMX and 8.5 (6.0; 11.0) for SCTG (p = .444). The respective PES scores at FU-1 were 9.0 (8.0;10.0) for VCMX and 9.0 (7.0;11.0) for SCTG, respectively (p = 1.000) ( Table 5 ).
T A B L E 4 Change in soft tissue volume and p-values (MWU test)
The PES score in the SCTG increased significantly up to 6 months with a median of 1.0 (0.0;3.0) (p = .039) compared to a loss of −0.5 (−2.0;0.5) (p = .406) for VCMX (intergroup comparison: p = .031). From baseline to 1 year, PES scores remained stable in both groups. The changes between the groups were not statistically significant (p = .409).
| Periodontaloutcomemeasures
All implant sites demonstrated stable and healthy peri-implant tissues at BL, 6M and FU-1. No significant differences were observed between the groups for any of the outcome measures PlI, BOP and PD (p > .05) (details see in Appendices S1-S3).
At BL, the KT at the buccal aspect of the implant showed a me- (Table 6 ).
| Patient-reportedoutcomemeasures
Median overall OHIP scores were 0 at all time points and in both groups (Table 7) .
| DISCUSSION
The .
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SD, standard deviation; Q1, first quartile; Q3, third quartile; VCMX, volumestable collagen matrix; SCTG, subepithelial connective tissue grafts; BL, baseline; 6M, follow-up at 6 months; FU-1, follow-up at 1 year. bold value: statistically significant.
T A B L E 6 Width of keratinized tissue (KT) and p-values (MWU test) and change in width of KT and p-values (MWU test)
VCMX ( .625 1.000 SD, standard deviation; Q1, first quartile; Q3, third quartile; VCMX, volumestable collagen matrix; SCTG, subepithelial connective tissue grafts; BL, baseline; 6M, follow-up at 6 months; FU-1, follow-up at 1 year. bold value: statistically significant. the implant sites both at 6 months and at 1 year of follow-up in the autogenous group (SCTG). Meanwhile, the volume remained stable in the VCMX group. Encompassing, however, the entire observation period, no relevant differences and changes were observed between the two groups. Scientific evidence assessing changes in peri-implant tissues following the insertion of final reconstructions is limited. In a prospective case series, 16 patients and sites were followed for 1 year after loading with final reconstructions. During that observation period, a labial volume loss of 0.04 ± 0.31 mm was recorded (Schneider et al., 2011) . The present study showed a slightly higher median volume loss of 0.1 mm for VCMX and 0.2 mm for SCTG. The study revealed a heterogeneous pattern of volume changes with a slight loss in an area closer to the mucosal margin and a slight gain in a more apical area. A high variability between patients and sites was observed, what could also be observed in the present investigation with a standard deviation of 0.5 mm (VCMX) and 0.2 mm (SCTG) after 1 year.
Longer-term data on volume changes in peri-implant tissues were reported by two recently published studies (De Bruyckere, Eghbali, Younes, De Bruyn, & Cosyn, 2015; Hanser & Khoury, 2016) . In a study reporting volume changes after implantation with a simultaneous connective tissue graft, 1 year after the insertion of the definitive implant-borne reconstructions, 50% of the reference points kept their volume from baseline to 1 year, whereas the other 50% showed a significant decrease (Hanser & Khoury, 2016) . Another prospective case series analysed implant sites in the aesthetic zone receiving a SCTG 3 months after implant placement. Mean soft tissue loss after 1 year was 0.10 ± 0.23 mm with no difference between patients with a thin or thick biotype (De Bruyckere et al., 2015) . These results are in accordance with the results of the present investigation, even though both studies used a slightly different method to analyse the changes in the peri-implant tissues.
More recently, the same method was used to evaluate volume changes in implant sites . Subepithelial connective tissue grafts were transplanted 3 months after implant placement. A median loss of −0.38 mm was observed at the buccal aspect 5 years after placement of the definitive reconstruction. In that study, however, abutment connection was performed 4-6 weeks after the soft tissue augmentation. Compared to the present study protocol, the earlier loading of the peri-implant soft tissues could have led to a slightly better tissue volume stability.
Soft tissues undergo changes beginning with the integration of the grafting material. Major changes can be expected up to the first 6 weeks after grafting (Studer, Lehner, Bucher, & Scharer, 2000; Rotenberg & Tatakis, 2014) . In the present study, the insertion of the final reconstruction was considered as baseline. All patients were then followed up for one more year. Therefore, soft tissue grafting procedures had been performed at least 4 months earlier. Volume changes based on the initial grafting and healing period (3 months) were reported previously (Thoma et al., 2016) . One could therefore speculate that at the baseline time point of the present non-interventional follow-up study, maturation of the augmented sites had already taken place. This would then explain rather stable peri-implant contour dimensions between the insertion of the final reconstruction and the 1-year follow-up.
Apart from more favourable aesthetics, data in the literature are controversial in terms of potential benefits on the health of the periimplant tissues following soft tissue grafting procedures. Studies have shown, though, that in case of implant sites with peri-implant disease, soft tissue grafting using SCTGs results in an improved peri-implant health (Schwarz, John, & Becker, 2015; Schwarz, John, Sahm, & Becker, 2014; . At implant sites with healthy peri-implant tissues, soft tissue grafting demonstrated to be beneficial with significantly less marginal bone loss . In the present study, marginal bone level changes were not assessed, and clinical indices for PD, PlI and BOP, however, were recorded. None of the assessed clinical parameters demonstrated any significant differences between the two groups, nor any significant changes over the 1-year observation period. These outcomes revealed that both treatment modalities rendered healthy peri-implant tissue.
Achieving a favourable aesthetic result is often a challenge for clinicians. Soft tissue grafting can be beneficial for implant sites regarding the aesthetic result (Cornelini, Barone, & Covani, 2008; Rungcharassaeng, Kan, Yoshino, Morimoto, & Zimmerman, 2012) .
To assess the aesthetic outcome of implant sites, numerous scoring systems and indices are available (Benic, Wolleb, Sancho-Puchades, & Hammerle, 2012; Cosyn, Thoma, Hammerle, & De Bruyn, 2017) .
Among the most frequently used indices is the so-called PES (Furhauser et al., 2005) . In the present study, both treatment groups achieved stable aesthetic results based on median PES scores of 9.0 (VCMX) and 8.5 (SCTG) at baseline and 9.0 (VCMX) and 9.0 (SCTG) at 1 year after loading. These results can also be explained by the case selection made in the present study. Every implant site was a single-tooth gap surrounded by natural teeth, presenting rather favourable conditions with the periodontium supporting the tissues of the adjacent implant. Moreover, the treatment protocol of the grafting procedure followed a delayed approach, at least 8 weeks after implant placement. In combination with a primary wound closure, the best possible blood supply provided the grafts and the healing wound. Abutment connection was performed 3 months after the grafting, followed by the fabrication of the definitive implant-supported reconstruction. This protocol allowed for a further maturation of the peri-implant tissues before the insertion of the reconstruction, thereby explaining stable aesthetic during the 1-year follow-up.
| CONCLUSION
Between crown insertion and 1 year, the buccal peri-implant soft tissue dimensions at implant sites revealed only minimal changes without relevant differences between sites that had previously been grafted with VCMX or SCTG. Periodontal parameters remained stable over time, and both treatment options resulted in aesthetically stable results over the entire observation time.
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